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Background: Organized screening programs are more effective and equitable than opportunistic screening, yet
governments face challenges to implement evidence-based programs. The objective of this study was to identify
reasons for low levels of adoption among primary care physicians of a government sponsored Cervical Screening
Program (CSP).
Methods: We conducted in-depth interviews with a snowball sample of primary care private and public primary
care physicians in Hong Kong. Rogers’ theory of diffusion of innovation was used to understand the factors that
influenced the physicians’ practice decisions.
Results: Our study found that Hong Kong physicians made the decision to encourage cervical screening and to
participate in the CSP based primarily upon their clinical and business practice needs rather than upon the scientific
evidence. The low rates of adoption of the CSP can be attributed to the physicians’ perceptions that the program’s
complexity and incompatibility exceeded its relative advantages. Furthermore, women’s knowledge, attitudes and
practices, identified as barriers by physicians, were also barriers to physicians adopting the CSP.
Conclusions: In both private and public health care systems, screening programs that rely on physicians must align
program incentives with the physicians’ motivators or pursue additional demand creation policies to achieve
objectives.
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Cervical cancer is relatively unique among cancers in
that its cause is known, it can be identified early and it
can be treated effectively at a pre-cancerous stage. Cer-
vical screening is most efficiently conducted as part of
an organised screening program; that is a program orga-
nised at the national or regional level, with explicit
evidence-based policies that include target populations,
frequency and treatment [1]. Compared to opportunistic
screening, which is done at the request of an individual
or her physician, organised programs have greater im-
pact on cancer incidence and mortality, more potential* Correspondence: csfabrizio@gmail.com
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distribution, and reproduction in any mediumto reduce disparities, higher cost effectiveness, and larger
effects on risk reduction for a population [2].
Hong Kong women suffer from a disproportionately
higher incidence of preventable morbidity and mortality
from cervical cancer than women in similarly industrial-
ized countries [3]. Hong Kong’s poorer results are attrib-
uted to the low rate of screening among women overall,
and to low screening rates among older and low-income
women in particular [4]. The major barriers to screening
among women in Hong Kong include age, lack of know-
ledge about the need for screening, socio-economic pos-
ition, and marital status, and are similar to the barriers
identified globally [5-10]. Research also indicated that
the women most at risk were more likely to report that
their doctor did not order or recommend the screen, or
that they did not know they needed a screen. Price has
not been identified as a major barrier.ntral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited.
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with the majority of outpatient primary care visits (about
85%) attributed to private medical or alternative medical
practitioners [11]. In the primary care system, physicians
with no specialty training are described as in General
Practice, while those in Family Medicine have received
fellowship certification in Family Medicine. In this mixed
public-private system, cervical screening in Hong Kong
has been conducted opportunistically by private practi-
tioners or as part of well-women health checks. This
screening was inefficient and inequitable, with poor
coverage of those at risk, and frequent screening of a mi-
nority of women that were more likely to be younger
and have more education [4]. In 1998, this opportunistic
system was estimated to be equivalent to an organised
program with only 50% coverage and 10-year screening
intervals [12].
In 2004, the Hong Kong government introduced the
Cervical Screening Program (CSP), an organised pro-
gram with the objectives of increasing the population
screening coverage rate and reducing the incidence and
mortality of cervical cancer [3]. Both physicians and
women were eligible to join individually. The CSP’s
evidence-based program components included recom-
mended age and frequency targets, quality assurance,
capacity for follow-up and treatment, and a registry for
surveillance and analysis. However, the CSP lacked other
evidence-based components, such as a national call-
recall system, interventions to increase provider screen-
ing recommendations, targeted interventions toward
those most at risk, and efforts to reduce inappropriate
over-screening. The CSP also did not provide any sub-
sidies to women to access care, nor to providers to in-
crease participation. Eight years after its introduction,
registration in the CSP is below 20% among both physi-
cians and women [13]. Population-based tracking data
reported women’s ever-screened rate of 63.3% in 2010,
essentially unchanged since the program began. In
addition, overall screening efficiency declined, with the
rate of over-screened, low-risk women (those who report
screens “once or more a year”) up from 56.0% in 2003,
pre-initiation of the CSP, to 62.8% in 2010 [3,14]. These
results indicate that the current structure and/or dissem-
ination strategy of the CSP may need to be modified.
The purpose of this study was to analyze physicians’
attitudes toward the CSP to identify reasons for low
levels of adoption of this organised cervical cancer
screening program. We drew upon Rogers’ Diffusion of
Innovation (DOI) theory [15] to guide the study. Rogers
defines adoption as “full use of an innovation as the best
course of action available” and rejection as a decision
“not to adopt an innovation” [15], p. 177. Furthermore,
he proposes five attributes or characteristics of innovation
that influence the adoption process: relative advantage,compatibility, complexity, trialability, and observability.
Our research questions drew upon these characteristics to
explore the adoption decision: 1) What are the physicians’
perceptions of the benefits of the CSP? 2) What are the
physicians’ perceptions of the program’s complexity? 3)
How compatible is the CSP with the physicians’ estab-
lished practices? 4) What is the perceived trialability of the
CSP? and 5) How observable is a physician’s participation
in the CSP to patients and other providers? We believe
that this work offers lessons for the international public
health community because it highlights barriers to dissem-
ination of public health programs that are common to
both private and public primary health care systems.Methods
We used the Hong Kong College of Community Medi-
cine as the sampling frame to identify Hong Kong physi-
cians whose practice included women in the screening
target age. Physicians were included if they were general
practice physicians or obstetrician/gynecological special-
ists, and excluded if they did not speak English at a level
needed to conduct the interview. The sampling strategy
utilized both snowball sampling, after the initial referrals
from the physicians’ association leaders and HKU School
of Public Health professors; and purposeful sampling, to
include a representative mix of genders, specialties, dis-
tricts and CSP-registered physicians. Sampling was more
difficult than anticipated, as only about half of the physi-
cians interviewed were willing or able to recommend a
colleague to interview. In an effort to recruit additional
physicians in different districts, particularly more men,
two physicians were recruited by “cold calling” physi-
cians on an insurance directory listing. Furthermore,
three physician leaders, two of which were known profes-
sionally to the lead author, were interviewed to explore
their perceptions of their association members, as well as
their own experiences with the CSP. Finally, due to a lack
of private practitioners who were knowledgeable about the
program, the sample also included three physicians who
worked in government or government-sponsored NGO
clinics (“clinic-based physicians”), which required their
physicians to register with the program.
All interviews were conducted in English, the language
of medical education in Hong Kong and there were no
language issues that affected acquisition or interpret-
ation of the interview data. Data collection continued
until data saturation was reached pertinent to the three
themes identified. The interviews were conducted over
the period of January to March 2011. Written consent
was obtained from each participant. The Institutional
Review Board of the University of Hong Kong and the
University of North Carolina at Chapel Hill, Office of
Human Research Ethics approved the study.
Table 1 Characteristics of physician sample
Characteristics Number
(n = 16)
Percentage
Gender
Female 12 75%
Male 4 25%
Specialty
General Practice 7 43.8%
Family Practice 7 43.8%
OB/GYN 2 12.5%
Years in practice
≤ 10 3 18.8%
11 ≤ 20 5 31.3%
> 20 8 50.0%
Practice size
One physician 5 31.3%
Small office
(2–6 physicians)
6 37.5%
Large clinic/
multi-site
5 31.3%
Average cervical screens
per month
≤10 7 43.8%
11 ≤ 50 3 18.8%
> 50 6 37.5%
Registered with CSP program
Yes 6 37.5%
No 10 62.6%
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of the characteristics of the program and the elements
that influenced their adoption decision. Given that rela-
tively few physicians were familiar with the CSP, the
interviews also included a discussion about a similar
government program, a flu vaccination subsidy. This vol-
untary program offered older residents a voucher to off-
set the cost of the vaccine given in a private physician’s
office. Similar to the structure of the CSP, this program
was a public-private partnership, aimed at a universal
population, and with many administrative requirements.
Data analysis
Coding and analysis were conducted using Dedoose
(Dedoose.com). Rogers’ theoretical framework guided
development of the codes, a priori. The first author
coded each interview transcript and created code sum-
maries, which were discussed with the second author.
To increase study reliability, all of the interviews were
double-taped, the transcripts were re-checked against
the audiotape and post-interview contact summary notes
as they were coded. Also, check-coding (i.e., recoding
transcripts to check for consistency) was used periodic-
ally to assess for potential code drift [16]. In order to im-
prove validity, interview summaries were examined for
discrepant viewpoints. Quotes were used to illustrate
themes and to present discrepant findings.
Results
A total of 24 physicians were identified and 16 physicians
accepted, for a response rate of 67%. Six physicians (38%)
were registered with the CSP and 12 (75%) were women
(Table 1). Seven (44%) of the respondents were in Family
Practice; seven (44%) were in General Practice (GP); and
two (13%) were OB/GYNs; doctor. Five physicians were in
solo practice (31%); five practiced in small groups of six or
less (38%); and the remaining five (31%) worked for gov-
ernment or large NGO multi-site practices. The respon-
dents had a range of experience, from six to 25 years,
and the sample was geographically and economically
heterogeneous.
Three themes, each pertinent to Rogers DOI theory,
emerged from the physician interviews (Table 2).
Theme 1: The CSP’s benefits were rarely meaningful to
the physicians’ practices
Most physicians identified the capability for recalling their
registered patients who had previously been screened, and
accessing those registered patients’ online screening history
as the most notable benefits of the CSP. However, these
benefits were not substantially better than their current
practices. For example, nine of the 10 physicians that
performed even a minimal number of Pap tests (at least 10
screens a month) already had a recall system. Mostphysicians felt that a recall system should be an essential
component of any general practice, for business reasons:
If the physicians don’t recall the women, the women
won’t come back. The physicians will lose the business,
right? That is why in that sense the Registry is of limited
help to one’s practice. You either determine to do this
kind of screening and you have your own system to
make sure this follow-up happens, or basically this is not
something that is a high priority in your practice
(Family Practice physician; registered with the CSP).
Although most physicians preferred to have access to
their patient’s past screening results to improve patient
care, many physicians perceived the online system to be
unnecessary, as physicians kept their regular patients’ past
records in their files and new patients generally knew a
sufficient amount about their past screening results for
the physicians to determine their clinical history.
Pap smear results are simple. The patient will know
if her past result is normal negative, or if there is
Table 2 Frequency of code usage
Code name Times
code
used
Code definition [15] Illustrative quotation
Relative
advantage
(benefit)
67 Degree to which an innovation is perceived as better than
the idea it supersedes.
“You either determine to do this kind of screening and you
would have your own system to make sure this follow-up or
basically this is not something high priority in your practice”.
Complexity 26 Degree to which an innovation is perceived as difficult to
understand and use.
“After you try it a few times you find it’s difficult; it’s just not
worthwhile.”
Compatibility 22 Degree to which an innovation is perceived as being
consistent with the existing values, past experiences, and
needs of potential adopters.
“It’s odd if you go see a doctor and then you mention you
thought of cervical screening. Will she think I’m trying to
get more money from her?
Trialability 5 Degree to which an innovation may be experimented with
on a limited basis.
“Actually I signed up but never used it.”
Observability 8 Degree to which the results of an innovation are visible to
others.
“If someone was already using the system and they are very
excited about it and they are telling me how the system
has been able to help their patient care.”
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afterward….So the information is already adequate
(OB/GYN physician; not registered with the CSP).
Five of the six physicians registered for the CSP did not
perceive any benefits from the program.
For a point of comparison against which to assess per-
ceived value of the CSP, participants were asked about
the value of the flu voucher program. This flu voucher,
which was a subsidy for patients that could be used with
any private provider, often was passed on as physician
revenue during an incremental visit. The physicians pre-
ferred this program to the CSP because of the increased
patient demand and the subsidy.
Why did I participate (in the flu vaccine program)? I
have lots of patients enrolled. So I think that it’s providing
an extra service to my patients…a lot of patients…a lot
more than from the cervical screening [program] (General
Practice physician; registered with the CSP).Why did I join the flu scheme instead of the CSP?
Because I get revenue from it (Family Practice
physician; not registered with the CSP).
In summary, the study physicians felt that the CSP did
not fulfill an information need or have a positive financial
impact, and that it was not demanded by their patients.Theme 2: CSP procedures were perceived as costly and
complex
Among the respondents who were familiar with the
CSP, the program was almost universally perceived to
be problematically complex. Often the physicians reported
that the program’s complexities negatively impacted their
practice costs or revenues. Physicians complained aboutthe staff training time required and the program’s on-
going administrative issues:
Well, it [administration] is complicated. Trying to
explain to the patients what to sign; filling in all the
forms; sending them in. If you are late you don’t get
paid. If the patient signs the wrong thing, you don’t get
paid. And you end up losing money. The patient never
comes back to pay (General Practitioner physician; not
registered with the CSP).
The flu vaccine was also perceived as administratively
complex. One physician succinctly summarized both
programs’ onerous administrative burdens: “Similar. Just
as bad.”
Physicians placed differing levels of importance on the
CSP’s complexity as a barrier to enrollment depending
on the degree to which their administrative staff could
manage the work. For those few physicians who had the
administrative capability, this complexity was manage-
able; however, most physicians had limited staff capabil-
ity. In Hong Kong, since few patients have insurance
coverage that requires physicians to complete burden-
some paperwork, physicians typically have minimal staff
for non-clinical care.
Theme 3: many physicians found the CSP policies
inconsistent with their usual clinical and business
practices
All the physicians interviewed stated their belief that cer-
vical screening was perhaps the most important preventive
care service, and most of the physicians interviewed said
that they often raised the issue with their patients. How-
ever, among physicians that regularly conducted cervical
screens, many raised concerns about the CSP’s compatibil-
ity with their preferred patient care practices for clinical
and business reasons. Most physicians stated that the
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ible with their usual practice, as they needed to be flexible,
for either clinical (patient) or customer satisfaction (busi-
ness) reasons. Sometimes physicians used annual screens
to trigger more complete check-ups:
Some of them [patients] are on the pill and they’re
actually having more partners than they like to admit.
So really part of the Pap smear screening isn’t just a
Pap smear screening; it’s also sexually transmitted
disease screening. So in fact I am merging the two
things together but that is working within the context
of being a doctor. If you look at just cervical screening
on its own, then there is nothing wrong with it
[screening every three years]. But of course the family
physician like me is looking at the patient as a holistic
person (Family Practice physician; not registered with
the CSP).
Other times the patients requested annual screens and
the physicians felt obligated to conduct one or she/he
risked losing the patient to a more accommodating
physician:
A lot of the Pap smears I do are actually people who
suggested that they wanted a health check, so they do
it every one to two years anyway. So they are the
people that are probably the ‘worried well’. So, yes,
they actually have a screen every year, so if I follow
the CSP [frequency policy] I will lose my client. It will
actually lose business for me (Family Practice
physician; not registered with the CSP).
Because some physicians screened as many as 50-100
women per month, they reported that reducing the fre-
quency of their patients’ cervical screens from every year
to every three years would likely reduce their revenue
from these preventive care visits significantly, by as
much as two-thirds.
Among those physicians that rarely screened their pa-
tients, many had attempted to increase screening rates,
but they faced barriers due to women’s knowledge, atti-
tudes and behaviors (KAP). For physicians serving
women in the lower socio-economic strata, their patient
population had little knowledge of cervical screening
and most physicians were reluctant to spend time edu-
cating and motivating their patients.
We have a lot more women with whom you would
have to reach out to initiate screening, because they
don’t have very much knowledge about it. With the
local population, if they don’t feel that they have
anything wrong with them, then they don’t feel the
need to do screening. They really don’t. The wholeconcept of this kind of preventive screening is not very
well established in the local Chinese population. They
are very inactive rather than proactive (General
Practice physician; not registered with the CSP).
At least half of the physicians who rarely screened
tended to have a fluid patient base as Hong Kong people
often change physicians frequently, even during the same
episode of illness. These physicians expressed concern that
new patients would be suspicious of opportunistic recom-
mendations and they spoke about needing to build trust
before recommending screening to their newer patients:
It [opportunistic screening] is one of the routine
questions I ask, especially with new patients. I usually
wouldn’t tell them to do it. I mean I’ll tell them, I’ll
ask them, but they usually won’t do it right away. The
reason being that I don’t want to make it sound like I
want to do it…because it’s not free for them. They have
to pay for it. I want to increase their readiness, but I
don’t want them to think that I am trying to do
business in a way (General Practice physician; not
registered with the CSP).
Even among women likely to undergo screening, phy-
sicians faced barriers, including women’s preferences for
female screeners or gynecological specialists. One male
physician who had trained overseas had restricted him-
self to simply reminding women to be screened, rather
than suggest that he perform the screen himself:
Some patients prefer female practitioners. They are
just not comfortable with a male doctor. So for these
patients I would not insist. But I will always remind
them to make sure they do have a gynecological
checkup with a Pap smear every two years (Male,
Family Practice physician, registered with the CSP).Some people ask me, “I want to have a cervical screen.
Can you introduce a specialist gynecologist for me?”
I said: “Have you talked with the doctor that you
usually go to see?” [And they reply] “No, I am not
going to talk to him. I think it has to be done by a
gynecologist specialist for this” (Female, Family
Practice physician, not registered with the CSP).
These physicians found it almost futile to make the ef-
fort to encourage their patients to be screened and
therefore did not see the benefit to enrolling in the CSP.
Discussion
Our study found that Hong Kong physicians made the de-
cision to encourage cervical screening and to participate
in the CSP or to follow its guidelines based primarily upon
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the scientific evidence. The low rates of adoption of the
CSP can be attributed to the physicians’ perceptions that
the program’s complexity and incompatibility exceeded its
relative advantages. Furthermore, women’s knowledge, at-
titudes and practices, identified as barriers by physicians,
were also barriers to physicians adopting the CSP. Our
study finding of the physicians’ negative perceptions of the
program, coupled with the individual nature of the pa-
tient–physician screening decision, indicate that the pro-
gram’s strategic focus on the private sector physician
should be re-assessed to either add physician incentives or
to refocus on increasing population-based demand.
Both private and public health care systems have strug-
gled to disseminate evidence-based screening programs
among primary care physicians; however, although Rogers
DOI theory has been applied in such diverse fields as
international development, education and HIV [17], there
is little evidence on the application of Rogers’ DOI on can-
cer screening guidelines. Glasgow et al.’s report [18] on a
National Cancer Institute-sponsored workshop acknowl-
edged the need to design dissemination into the plan-
ning stage of a policy and recommended that theories
or models should guide implementation.
In England, physician adoption of a cervical screening
program in the 1990’s was not broadly successful until
motivators and incentives were aligned. Initially the pro-
gram did not offer a financial incentive, but when it was
added screening coverage rose from 42% to 85% from
1990 to 1998, with over 90% of physicians reaching a
target of over 80% of their patients’ screened [19]. In the
United States, although policy makers typically worked
with the private sector to issue screening guidelines, sur-
veillance of primary care physicians’ cervical screening
practices shows that many physicians did not follow
screening guidelines during the period 2005-2010, for
similar clinical and business practice reasons to those
shown in this study [20]. Furthermore, a 2011 survey of
obstetrician-gynecologists reported that only approxi-
mately half of these specialists followed guidelines for
Pap and HPV testing [21]. Demand-generating policies,
such as the CDC’s National Breast and Cervical Cancer
Early Detection Program, have had some success in in-
creasing targeted breast and cervical screening coverage
by providing subsidies to the most underscreened [22].
Consistent with these experiences in the U.S. and
England, our study suggests two important lessons for
public health programs. First, when a program depends
upon physicians to achieve its goals, the program incen-
tives must align with physicians’ motivations. In a pri-
vate primary care system, the financial viability of their
primary care practice is a key motivator, so financial in-
centives may be warranted. Also notable, however, is
the lack of active participation among the physiciansemployed by semi-public clinics because their institu-
tions managed most of the administrative aspects of the
program. Therefore, even with the potential to mitigate
the complexity of the program (Theme 2), and although
business priorities did not apply (Theme 3), the lack of
perceived benefits (Theme 1) impeded these physicians’
participation in the program. Second, governments may
be more successful by focusing on demand-generating
policies that they can control, such as population-based
invitations, subsidies for high-risk women, and expanded
capacity in larger clinic-based settings. These will encour-
age private physicians to overcome their objections to the
administrative requirements.
This study had some limitations. First, it was difficult to
identify and recruit private physicians who were both reg-
istered and active in the program, so the findings may not
adequately represent the perspectives of all private phy-
sicians. However, perceptions of the registered private
physicians interviewed were consistent with those of the
unregistered physicians, and with the semi-public clinic-
based registered physicians. Second, because our study
was qualitative and exploratory, the results are not gene-
ralizable to other settings and programs. However, we
believe the study could inform hypotheses for future stud-
ies focusing on the CSP participation rates, or adoption
decisions of other programs. Third, although 70% of Hong
Kong physicians were estimated to be male [23] only
four of the 16 respondents (25%) were men, due to a
disproportionate number of female physicians referred
during the recruitment process, as well as a substantial
difference between response rates for female versus
male physicians. However, given women’s screening
preference for female physicians, this group may have
been more likely to have been involved in the CSP and
more knowledgeable about cervical screening practices.
Finally, prior to the study, the primary author already
knew two of the physicians interviewed. This profes-
sional relationship could have introduced bias. How-
ever, we do not believe such bias was an issue in our
study because interviews with these physicians’ yielded
data that was consistent with interviews of physicians
who were not known to the researcher.
Conclusions
Organised screening programs are more effective and
equitable than opportunistic screening yet governments
are challenged to implement evidence-based programs
through primary care physicians. This study suggests
that the individual clinical and business needs of private
physicians can impede public health program dissemin-
ation. Even physicians in semi-public settings, without
the same business needs of their private practice coun-
terparts, are unlikely to embrace a program if the bene-
fits are not perceived as valuable. Therefore, programs
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incentives are aligned with their motivations. If a pro-
gram is unable to do so, it might be best served by pur-
suing demand-creation strategies that are not reliant
upon the physicians.
Competing interests
The authors declare they have no competing interests.
Authors’ contributions
CF was the principal investigator of the study and took the lead role in
conceptualizing and drafting the manuscript. CS contributed to the
conceptualization and editing of the manuscript. Both authors read and
approved the final manuscript.
Acknowledgements
Christopher Shea is currently supported by a career development award
(KL2TR001109) through the North Carolina Translational and Clinical Sciences
(NC TraCS) Institute at the University of North Carolina - Chapel Hill, which is
funded through the NIH Clinical and Translational Science Awards (CTSA)
(UL1TR001111). The content is solely the responsibility of the authors and
does not necessarily represent the official views of the NIH.
Author details
1School of Public Health, University of Hong Kong, 5th Floor, William MW
Mong Block, 21 Sassoon Road, Pokfulam, Hong Kong, SAR, China.
2Department of Health Policy and Management, Gillings School of Global
Public Health, University of North Carolina-Chapel Hill, Chapel Hill, NC, USA.
Received: 13 June 2013 Accepted: 18 February 2014
Published: 25 February 2014
References
1. World Health Organization, International Agency for Research on Cancer:
IARC handbook of cancer prevention. Volume 10 Lyons. In [http://www.
iarc.fr/en/publications/pdfs-online/prev/handbook10/index.php]
2. Miles A, Cockburn J, Smith RA, Wardle JA: Perspective from countries using
organized screening programs. Cancer Suppl 2004, 101:1203–1213.
3. Department of Health, Surveillance and Epidemiology Branch, Centre for
Health Protection, Government of the Hong Kong Special Administrative
Region: Topical health report #4: Prevention and screening of cervical cancer.
Hong Kong: Hong Kong Government; 2004.
4. Adab P, McGhee S, Yanova J, Wong LC, Wong CM, Hedley AJ: The pattern
of cervical screening in Hong Kong. Hong Kong. In Health Services
Research Committee/Health Care and Promotion Fund, Department of
Community Medicine, University of Hong Kong. Hong Kong; 2000.
5. Blomberg K, Temestedt BM, Tornberg S, Tishelman C: How do women who
choose not to participate in population-based cervical cancer screening
reason about their decision? Psycho-Oncology 2008, 17:561–569.
6. Eaker S, Adami H, Sparé P: Reasons women do not attend screening for
cervical cancer: a population-based study in Sweden. Prev Med 2001,
32:482–491.
7. Leung S, Leung I: Cervical cancer screening: knowledge, health
perception and attendance rate among Hong Kong Chinese women.
Int J Womens Health 2010, 2:221–228.
8. Hewitt M, Devesa S, Breen N: Cervical cancer screening among U.S.
women: analyses of the 2000 National Health Interview Survey.
Prev Med 2004, 39:270–278.
9. Waller J, Bartoszek M, Marlow L, Wardle J: Barriers to cervical cancer
screening attendance in England: a population-based survey.
J Med Screen 2009, 16:199–204.
10. Twinn S, Holroyd E, Fabrizio C, Moore A, Dickinson J: Increasing knowledge
and uptake of screening of cervical cancer amongst Hong Kong Chinese
women over 40 years: an evaluation of a health promotion programme.
In No. 218012 Hong Kong: Health Care and Promotion Fund. Hong Kong:
Hong Kong Government; 2005.
11. Bauhinia Foundation Research Centre Health Care Study Group, Hong Kong:
Development and financing of Hong Kong’s future health care, Final Report.
Hong Kong: Bauhinia Foundation; 2007.12. Woo PP, Thach TQ, Choy ST, McGhee SM, Leung GM: Modeling the impact
of population-based cytologic screening on cervical cancer incidence
and mortality in Hong Kong; an age-period-cohort approach.
Br J Cancer 2005, 93:1077–1083.
13. Department of Health, Government of the Hong Kong Special
Administrative Region: Annual statistics of the Cervical Screening
Programme 2010. [https://www.cervicalscreening.gov.hk/textonly/english/
sr/sr_statistics_as.html]
14. Department of Health, Government of the Hong Kong Special
Administrative Region, and Department of Community Medicine, University
of Hong Kong: Population Health Survey 2003-2004. [http://www.chp.gov.hk/
files/pdf/report_on_population_health_survey_2003_2004_en.pdf]
15. Rogers EM: Diffusion of innovation. 5th edition. New York: Free Press, a
division of Simon and Schuster, Inc; 2003.
16. Huberman AM, Miles MB: The qualitative researcher’s companion. Thousand
Oaks: Sage; 2002.
17. Moseley SF: Everett Rogers’ diffusion of innovations theory: its utility and
value in public health. J Health Commun 2004, 9(S1):149–151.
18. Glasgow RE, Marcus AC, Bull SS, Wilson KM: Disseminating effective cancer
screening interventions. Cancer 2004, 101(S5):1239–1250.
19. Patnick J: Cervical cancer screening in England. Eur J Cancer 2000,
36(17):2205–2208.
20. Martires M, Kurlander DE, Minwell GJ, Dahms EB, Bordeaux JS: Patterns of
cancer screening in primary care from 2005 to 2010. Cancer 2014,
120.2:253–261.
21. Perkins RB, Anderson BL, Gorin SS, Schulkin JA: Challenges in cervical
cancer prevention: a survey of U.S. obstetrician-gynecologists.
Am J Prev Med 2013, 45(2):175–181.
22. Smith RA, Cokkinides V, Eyre HJ: Cancer screening in the United States,
2007: a review of current guidelines, practices, and prospects.
CA, Cancer J Clin 2007, 57:90–104.
23. Li DK: Primary care in Hong Kong. Asia Pac Fam Med 2003, 2:2–4.
doi:10.1186/1472-6963-14-85
Cite this article as: Fabrizio and Shea: Disseminating a cervical cancer
screening program through primary physicians in Hong Kong: a
qualitative study. BMC Health Services Research 2014 14:85.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
